Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men
The paper outlines the author's experience on the efficacy and safety of androgen therapy of metabolic syndrome and obesity in men with hypogonadism. The study used testosterone undecanoate therapy that reduced body fat and the severity of the other components of the metabolic syndrome, improve...
Format: | Article |
---|---|
Language: | English |
Published: |
Endocrinology Research Centre
2013-03-01
|
Series: | Ожирение и метаболизм |
Subjects: | |
Online Access: | https://endojournals.ru/index.php/omet/article/view/5071 |
id |
doaj-ee23bcd862fd4dbbb5882ee580f4a5c5 |
---|---|
record_format |
Article |
spelling |
doaj-ee23bcd862fd4dbbb5882ee580f4a5c52021-10-02T16:09:33ZengEndocrinology Research CentreОжирение и метаболизм2071-87132306-55242013-03-01101434610.14341/2071-8713-50715029Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in menThe paper outlines the author's experience on the efficacy and safety of androgen therapy of metabolic syndrome and obesity in men with hypogonadism. The study used testosterone undecanoate therapy that reduced body fat and the severity of the other components of the metabolic syndrome, improved sexual function without causing severe side effects. A number of patients on therapy observed suppression of spermatogenesis, which prevents the use of the drug in the reproductive rehabilitation.https://endojournals.ru/index.php/omet/article/view/5071тестостерона ундеканоатожирениеметаболический синдроммужчиныгипогонадизмандрогенная терапия |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
title |
Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men |
spellingShingle |
Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men Ожирение и метаболизм тестостерона ундеканоат ожирение метаболический синдром мужчины гипогонадизм андрогенная терапия |
title_short |
Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men |
title_full |
Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men |
title_fullStr |
Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men |
title_full_unstemmed |
Experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men |
title_sort |
experience of using long-acting testosterone undecanoate in hypogonadism, obesity and metabolic syndrome in men |
publisher |
Endocrinology Research Centre |
series |
Ожирение и метаболизм |
issn |
2071-8713 2306-5524 |
publishDate |
2013-03-01 |
description |
The paper outlines the author's experience on the efficacy and safety of androgen therapy of metabolic syndrome and obesity in men with hypogonadism. The study used testosterone undecanoate therapy that reduced body fat and the severity of the other components of the metabolic syndrome, improved sexual function without causing severe side effects. A number of patients on therapy observed suppression of spermatogenesis, which prevents the use of the drug in the reproductive rehabilitation. |
topic |
тестостерона ундеканоат ожирение метаболический синдром мужчины гипогонадизм андрогенная терапия |
url |
https://endojournals.ru/index.php/omet/article/view/5071 |
_version_ |
1716852768359055360 |